```html

Jarisch‑Herxheimer Reaction (JHR)

Overview

The Jarisch‑Herxheimer reaction (JHR) is an acute, systemic inflammatory response that can occur after the initiation of antimicrobial therapy for certain spirochetal infections. It is most famously associated with treatment of Treponema pallidum (syphilis) but is also reported with infections such as leptospirosis, relapsing fever, Lyme disease, and bacterial vaginosis caused by Gardnerella vaginalis.

Key points

• What it is: A transient flare of fever, chills, headache, and other symptoms caused by the rapid death of bacteria and the release of endotoxin‑like substances.
• Who it affects: Anyone receiving appropriate antimicrobial therapy for a susceptible infection, though it is most common in patients with early syphilis.
• Prevalence: In early syphilis, JHR occurs in 10‑30 % of patients treated with penicillin; rates are higher (up to 50 %) in those with secondary or early latent disease (CDC, 2023). For Lyme disease treated with doxycycline, the reaction is reported in roughly 5‑10 % of cases.

Symptoms

Symptoms typically begin within 30 minutes to 2 hours after the first dose of antibiotics and resolve within 24 hours, although a milder, prolonged course can occur.

General constitutional symptoms

• Fever – sudden rise of 1‑3 °C (2‑5 °F), often with chills.
• Chills or rigors – shaking episodes that may last several minutes.
• Headache – usually diffuse, can mimic migraine.
• Myalgia – muscle aches, especially in the neck, back, and limbs.
• Fatigue – profound tiredness out of proportion to the underlying infection.

Cardiovascular and respiratory

• Rapid heart rate (tachycardia) 100‑120 bpm.
• Transient low blood pressure (hypotension) in severe cases.
• Shortness of breath or feeling “tight‑chested.”

Dermatologic

• Flushing or feeling hot.
• Exacerbation of existing rash (e.g., syphilitic rash, erythema migrans in Lyme).
• Urticaria‑like hives (rare).

Neurologic

• Dizziness or light‑headedness.
• Transient worsening of neurologic symptoms such as meningismus in neurosyphilis.
• Rarely, seizures (mostly reported in severe leptospirosis JHR).

Gastro‑intestinal

• Nausea, vomiting, or mild abdominal cramps.

Causes and Risk Factors

JHR is not an allergic reaction; it results from the sudden release of bacterial lipoproteins, endotoxin‑like molecules, and inflammatory mediators (TNF‑α, IL‑6, IL‑8) when large numbers of organisms die.

Primary causes

• Syphilis – especially early stages (primary, secondary, early latent).
• Relapsing fever – caused by Borrelia spp.; reaction can be severe.
• Lyme disease – B. burgdorferi infection treated with doxycycline, cefuroxime, or IV ceftriaxone.
• Leptospirosis – Leptospira interrogans infection, especially with severe (Weil’s) disease.
• Other spirochetal infections – e.g., syphilitic hepatitis, neurosyphilis.

Risk factors for a more pronounced JHR

• High bacterial load (e.g., secondary syphilis rash, high leptospiral titers).
• Prompt, high‑dose antimicrobial therapy (penicillin G 2.4 million units IM, IV ceftriaxone 2 g).
• Pregnancy – immune modulation may affect severity.
• Co‑existing cardiovascular disease that reduces physiologic reserve.

Diagnosis

JHR is a clinical diagnosis. No laboratory test confirms it, but labs can help rule out other causes of fever.

Clinical criteria

1. Recent initiation (within 2 hours) of appropriate antimicrobial therapy for a spirochetal infection.
2. Acute onset of fever, chills, and at least one systemic symptom.
3. Symptoms resolve within 24 hours without need for additional antimicrobial changes.
4. Absence of an alternative explanation (e.g., drug allergy, bacterial super‑infection).

Supporting investigations

• Complete blood count (CBC): May show transient leukocytosis.
• C‑reactive protein (CRP) / ESR: Elevated but non‑specific.
• Blood cultures: Usually negative; performed to exclude septicemia.
• Serologic titers: Baseline RPR/VDRL for syphilis, Lyme IgM/IgG – useful for documenting infection but not the reaction.
• Vital signs monitoring: Document fever spikes, tachycardia, blood pressure changes.

Treatment Options

Because JHR is self‑limited, treatment focuses on symptom control and prevention of complications.

Pharmacologic measures

• Aspirin 325‑650 mg PO or acetaminophen 650‑1000 mg PO every 4‑6 h for fever and headache (avoid NSAIDs in severe renal impairment).
• Anti‑inflammatory agents: One dose of oral prednisolone 20‑40 mg may be considered in severe relapsing fever JHR, though evidence is limited.
• IV fluids: 500‑1000 mL of isotonic saline to maintain blood pressure for patients with hypotension.
• Antipyretics: Continue as needed; do not discontinue the primary antibiotic.

Procedural/Supportive care

• Continuous vital sign monitoring for 2‑4 hours after the first dose.
• Oxygen supplementation if SpO₂ < 94 %.
• Rapid response team activation for severe hypotension or arrhythmias.

Lifestyle/adjunct measures

• Rest in a cool, well‑ventilated environment.
• Hydration: encourage oral fluids (water, electrolyte solutions) unless contraindicated.
• Cool compresses to forehead or neck.

Living with Jarisch‑Herxheimer Reaction

Most patients experience only a brief episode and can continue their antibiotic regimen. Below are practical tips for daily life during treatment.

• Plan the first dose when you can rest: Take the initial dose at home or in a setting where you can stay seated for at least 2 hours.
• Keep a symptom diary: Note the time of medication, temperature, heart rate, and any new symptoms. This helps clinicians differentiate JHR from other problems.
• Stay hydrated: Aim for 2‑3 L of fluid per day unless advised otherwise.
• Use over‑the‑counter analgesics: Have acetaminophen or aspirin readily available.
• Inform close contacts: They may need to be aware in case they notice you becoming suddenly ill.
• Adhere to the full antibiotic course: Stopping therapy early may lead to treatment failure or relapse.

Prevention

While JHR cannot be completely avoided, the risk and severity can be mitigated.

• Gradual dosing when possible: In some relapsing fever protocols, a lower initial dose of doxycycline is given and escalated after 12 hours.
• Pre‑treatment with antipyretics: Taking acetaminophen 30 minutes before the first antibiotic dose may blunt the fever spike (supported by limited RCT data in syphilis).
• Early diagnosis: Treating infections before the bacterial load becomes high lowers JHR incidence.
• Pregnant patients: Coordinate with obstetrics; low‑dose aspirin may be used under supervision.

Complications

When JHR is mild, complications are rare. Severe reactions can lead to:

• Hemodynamic instability: Prolonged hypotension, leading to syncope or shock.
• Exacerbation of existing cardiac disease: Arrhythmias or myocardial ischemia in patients with coronary artery disease.
• Neurologic worsening: Increased intracranial pressure or seizures in neurosyphilis or Lyme meningitis.
• Renal impairment: Acute tubular necrosis secondary to hypotension.
• Fetal distress: Rare, but reported in pregnant women with severe reactions.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention. Syphilis – Treatment and Prevention. 2023.
• Mayo Clinic. Jarisch‑Herxheimer Reaction. Updated 2022.
• Cleveland Clinic. Relapsing Fever and Jarisch‑Herxheimer Reaction. 2021.
• World Health Organization. Leptospirosis Fact Sheet. 2022.
• National Institute of Allergy and Infectious Diseases. Lyme Disease Treatment Guidelines. 2023.

```